Folate Supplementation for Peripheral Neuropathy: A Systematic Review
Nutrients · 2025
DOI: 10.3390/nu17203299 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, 2025. Verfasst von Ana Carolina Alves Maues und 3 weiteren Autor:innen. Beteiligte Einrichtung: OPKO Health Spain S.L.U., Palol de Revardit, 17843 Girona, Spain. Hauptthemen laut MEDLINE: Folic Acid, Dietary Supplements, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: OPKO Health Spain S.L.U..
Abstract (Originalsprache)
Background
Peripheral neuropathy (PN) represents a considerable and rapidly growing global health burden, with diabetic PN alone impacting nearly half of diabetic patients. Evidence from experimental studies highlighted that folate supplementation may protect nerve health by supporting myelin maintenance, minimizing oxidative stress, and enhancing neurotrophic factors. Nevertheless, its clinical efficacy and safety in managing PN have not yet been established. This study seeks to evaluate the role of folate in managing PN regarding the efficacy and safety endpoints.
Methods
Up to July 2025, a comprehensive search of four electronic databases, encompassing PubMed, Scopus, Web of Science, and Cochrane Library, was executed, collecting studies evaluating the folate in managing PN. Outcomes included pain scores, symptom improvement endpoints, Neuropathy Total Symptom Score (NTSS) scores, epidermal nerve fiber density (ENFD), biomarkers, and side effects.
Results
The narrative synthesis demonstrated consistent symptomatic benefits with pain reductions reaching 3 points, with symptom resolution rates of 87.5% and NTSS-6 score enhancements varying from 0.9 to 1.5 points. Notably, objective structural improvements in ENFD were observed, with increases reaching 97%. Furthermore, folate showed an excellent safety and tolerability profile with only one adverse event reported among 1367 individuals. Folate significantly decreased homocysteine and high-sensitivity C-reactive protein (hs-CRP) levels.
Conclusions
Folate showed promising symptomatic benefits for peripheral neuropathy, with objective structural improvements (ENFD) and favourable biomarker changes (homocysteine, hs-CRP reduction), with an excellent safety profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- OPKO Health Spain S.L.U., Palol de Revardit, 17843 Girona, Spain.
- Department of Basic Biomedical Sciences, Catholic University of Valencia San Vicente Mártir, 46001 Valencia, Spain.
- Institute for Research on Musculoskeletal Disorders, Catholic University of Valencia San Vicente Mártir, 46001 Valencia, Spain.
ORCID-Profile: María Benlloch, Gonzalo Mariscal
Förderung
- OPKO Health Spain S.L.U.
Zitieren
APA
Alves Maues, A. C., Moren Abat, M. G., Benlloch, M., & Mariscal, G. (2025). Folate Supplementation for Peripheral Neuropathy: A Systematic Review. Nutrients. https://doi.org/10.3390/nu17203299
Vancouver
Alves Maues AC, Moren Abat MG, Benlloch M, Mariscal G. Folate Supplementation for Peripheral Neuropathy: A Systematic Review. Nutrients. 2025. doi:10.3390/nu17203299
BibTeX
@article{AlvesMaues2025,
author = {Alves Maues, Ana Carolina and Moren Abat, Mònica Gemma and Benlloch, María and Mariscal, Gonzalo},
title = {Folate Supplementation for Peripheral Neuropathy: A Systematic Review},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17203299}
}
EUVIMED